Novigenix SA vs SENSEERA
Novigenix SA
Leader in Immuno-Transcriptomic Precision Medicine solutions
26 employees · est. 2014 · Lausanne, Switzerland
SENSEERA
Empowering diagnostics and drug development with AI-driven chromatin liquid biopsy
20 employees · est. 2020 · Jerusalem, Israel
Novigenix SA is the older company (2014 vs 2020).
Side-by-Side Comparison
| Metric | Novigenix SA | SENSEERA |
|---|---|---|
| Founded | ||
| Founded | 2014 older | 2020 |
| Headquarters | ||
| Headquarters | Lausanne, Switzerland | Jerusalem, Israel |
| Employees | ||
| Employees | 26 | 20 |
| Industry | ||
| Industry | AI, Analytics, Biotechnology | Health Care |
| Funding Stage | ||
| Funding Stage | Series B | Not tracked yet |
| Total Funding | ||
| Total Funding | $21.00M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 2 | Not tracked yet |
| Services | ||
| Services | Not tracked yet | AI-driven chromatin liquid biopsy, Diagnostic platform for disease monitoring, Non-invasive gene expression analysis, Biomarker generation for treatment monitoring |
| Target Customers | ||
| Target Customers | Not tracked yet | Pharmaceutical companies, Biotechnology firms, Clinical researchers, Healthcare providers, Diagnostic laboratories |
| Taxonomy | ||
| Taxonomy | Precision MedicineImmunoTranscriptomicsAI In HealthcareCancer ManagementMulti-omics Data AnalysisTherapy Optimization +7 | AI-driven DiagnosticsChromatin Liquid BiopsyBiomarker DiscoveryGenomic Expression MapsCell-free DNA AnalysisTissue-agnostic MRD Detection +9 |
| Website | ||
| Website | novigenix.com | senseerahealth.com |
About Novigenix SA
NOVIGENIX is a Swiss precision medicine company founded in 2014 that focuses on leveraging ImmunoTranscriptomic technologies to revolutionize disease management, with a primary focus on cancer. Through their proprietary LITOseek platform, which incorporates advanced Machine Learning and artificial i...
About SENSEERA
SENSEERA is a promising player in the Health Care sector, founded in 2020 and based in Israel. The company is pioneering advancements in diagnostics and drug development with its AI-driven chromatin liquid biopsy technology. The foundation of SENSEERA's innovation is its patented GEM (Genomic Expre...
Also comparing in this category
Comparing more than these two?
Get Novigenix SA, SENSEERA and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Novigenix SA compare?
A PDF of Novigenix SA and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Novigenix SA with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Novigenix SA on 11 Sep 2024, and SENSEERA on 5 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.